<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: JANUARY 27, 1999
DATE OF EARLIEST EVENT REPORTED: JANUARY 25, 1999
UNITED MEDICORP, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
COMMISSION FILE NUMBER 1-10418
DELAWARE 75-2217002
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
10210 NORTH CENTRAL EXPRESSWAY
SUITE 400
DALLAS, TEXAS 75231
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (214) 691-2140
_____________________________ N.A.
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
<PAGE>
UNITED MEDICORP, INC. AND SUBSIDIAIRIES
ITEM 4. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT
(a) On January 25, 1999, the Audit Committee of the Board of Director's of
United Medicorp, Inc. (the "Registrant") accepted the resignation of the firm of
PricewaterhouseCoopers LLP as the Registrant's independent auditor.
(b) The reports of PricewaterhouseCoopers LLP on the Registrant's
financial statements for the two years ended December 31, 1997 did not contain
an adverse opinion or a disclaimer of opinion and were not qualified or modified
as to uncertainty, audit scope or accounting principles, except that the report
of PricewaterhouseCoopers LLP on the Registrant's financial statements for the
year ended December 31, 1996 included an explanatory paragraph relating to an
uncertainty about the Registrant's ability to continue as a going concern.
(c) There were no disagreements with PricewaterhouseCoopers LLP during the
audits of the Registrant's financial statements for the two years ended December
31, 1997, and any subsequent interim period preceding the change on any matter
of accounting principles or practices, financial statement disclosure, or
auditing scope or procedure, which disagreement, if not resolved to the
satisfaction of PricewaterhouseCoopers LLP, would have caused it to make
reference to the subject matter of the disagreement in connection with its
report.
(d) On January 25, 1999, the Registrant appointed Hein + Associates LLP as
its independent accountant and Hein + Associates LLP accepted such appointment.
(e) The Registrant had no relationship with Hein + Associates LLP required
to be reported pursuant to Regulation S-K Item 304. (a)(2) during the two years
ended December 31, 1997 or the subsequent interim period prior to and including
January 25, 1999.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
<TABLE>
<CAPTION>
Exhibit Number Description
-------------- -----------
<S> <C>
16.1 Letter of PricewaterhouseCoopers LLP to the Securities
and Exchange Commission included herein pursuant to the
requirements of Item 304(a) of Regulation S-K.
</TABLE>
2
<PAGE>
UNITED MEDICORP, INC. AND SUBSIDIARIES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
UNITED MEDICORP, INC.
(REGISTRANT)
By: /s/ R. Kenyon Culver Date: January 27, 1999
------------------------------------------- -----------------
R. Kenyon Culver
Vice President and Chief Financial Officer
(Principal Accounting Officer)
3
<PAGE>
UNITED MEDICORP, INC. AND SUBSIDIARIES
EXHIBIT 16.1 TO FORM 8-K
(Letterhead of PricewaterhouseCoopers LLP)
PricewaterhouseCoopers LLP
2001 Ross Avenue, Suite 1800
Dallas, Texas 75201-2997
Telephone (214) 754-7900
January 25, 1999
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read Item 4 of United Medicorp, Inc.'s Form 8-K dated January 27, 1999
and are in agreement with the statements contained in paragraphs 4(a)-(c)
therein.
Yours very truly,
/s/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP
